title: Recovery after ischemic stroke: criteria for good outcome by level of disability at day 7.
abstract: BACKGROUND
  Ischemic stroke is a leading cause of morbidity. Assessing the chances of recovery is critical to optimize poststroke care.
  
  
  METHODS
  We used a cohort of patients from the Virtual International Stroke Trial Archive that participated in acute stroke trials (control arm) and were followed for 90 days. The cohort was grouped by day 7 (D7) modified Rankin scale (mRS) scores. Variables that were associated with good outcome (mRS 0-2 at 90 days) in the univariate analysis were entered into a logistic regression model to determine the independent good outcome criteria for each D7 mRS tier.
  
  
  RESULTS
  We analyzed 1,798 patients. The independent good outcome criteria identified for different mRS tiers were: D7 mRS of 3: age < or =70, 0-2 vascular risk factors, D7 NIH Stroke Scale (NIHSS) arm strength < or =1, D7 NIHSS language score = 0; D7 mRS of 4: age < or =70, male, D7 NIHSS facial palsy < or =1, D7 NIHSS visual = 0, D7 NIHSS leg strength < or =1, D7 NIHSS dysarthria = 0; D7 mRS of 5: age < or =70, IV tPA treatment, D7 NIHSS dysarthria = 0, D7 NIHSS leg strength < or =2. For each mRS tier, we observed a graded increase in the percentage of the primary and secondary end points with increase in the number of criteria.
  
  
  CONCLUSIONS
  We identified clinical variables that predict good outcome, are specific to each day 7 mRS tier, and enable easy and informative assessment of the patient's likelihood of achieving varying degrees of recovery at day 90. These results may be useful in both clinical practice and research but require validation in an independent patient cohort.
authors.affiliation: Department of Neurology, Vascular Neurology Program, University of Texas at Houston Health Science Center, Houston, Texas 77030, USA.
authors.forename: Hen
authors.initials: H
authors.lastname: Hallevi
authors.forename: Karen C
authors.initials: KC
authors.lastname: Albright
authors.forename: Sheryl B
authors.initials: SB
authors.lastname: Martin-Schild
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Barreto
authors.forename: Miriam M
authors.initials: MM
authors.lastname: Morales
authors.forename: Natan
authors.initials: N
authors.lastname: Bornstein
authors.forename: Nneka L
authors.initials: NL
authors.lastname: Ifejika
authors.forename: Ashfaq
authors.initials: A
authors.lastname: Shuaib
authors.forename: James C
authors.initials: JC
authors.lastname: Grotta
authors.forename: Sean I
authors.initials: SI
authors.lastname: Savitz
mesh_terms: D000368:Aged; D002545:Brain Ischemia / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D004185:Disability Evaluation; D005260:Female; D006305:Health Status Indicators; D006801:Humans; D016015:Logistic Models; D008297:Male; D016017:Odds Ratio; D011237:Predictive Value of Tests; D020127:Recovery of Function; D012042:Registries; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D020521:Stroke / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D013997:Time Factors; D016896:Treatment Outcome